Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hairy cell leukemia.

J Jansen1

  • 1Department of Medicine, Indiana University, Indianapolis.

Critical Reviews in Oncology/Hematology
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Hairy cell leukemia, a mature B-cell disorder, has evolving treatments. Splenectomy was standard, but newer therapies like alpha-interferon and deoxycoformicin show promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Soft tissue injuries of the face; a summary with practical guidelines].

Nederlands tijdschrift voor tandheelkunde·2026
Same author

Perceptions, facilitators and barriers of digital interdisciplinary consultation: a qualitative study.

Family practice·2025
Same author

[Tetanus: a rare, life-threatening infection with trismus as a symptom].

Nederlands tijdschrift voor tandheelkunde·2025
Same author

IL-15 transpresentation by ovarian cancer cells improves CD34<sup>+</sup> progenitor-derived NK cell's anti-tumor functionality.

Oncoimmunology·2025
Same author

A semi-permeable insert culture model for the distal part of the nephron with human and mouse tubuloid epithelial cells.

Experimental cell research·2024
Same author

The impact of different radiology report formats on patient information processing: a systematic review.

European radiology·2024
Same journal

Remodeling the Immune Microenvironment: Engineering IL-2 Variants to Overcome Clinical Bottlenecks in PD-1 Inhibitor plus Chemotherapy.

Critical reviews in oncology/hematology·2026
Same journal

Neoadjuvant Immunotherapy in Melanoma: From Pathologic Response to Response-Adapted Management.

Critical reviews in oncology/hematology·2026
Same journal

DNA polymerase epsilon catalytic subunit (POLE) in cancer: Implications for tumor biology and therapeutic strategies - A comprehensive review.

Critical reviews in oncology/hematology·2026
Same journal

Long non-coding RNAs in triple-negative breast cancer: emerging drivers of tumor biology, prognosis, and drug resistance.

Critical reviews in oncology/hematology·2026
Same journal

Alternative splicing in breast cancer drug resistance: Mechanisms, therapeutic targeting, and clinical translation.

Critical reviews in oncology/hematology·2026
Same journal

Gene fusions in non-small cell lung carcinoma (NSCLC): Expert perspectives and practical considerations for routine testing.

Critical reviews in oncology/hematology·2026
See all related articles

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Hairy cell leukemia (HCL) is a distinct chronic lymphoproliferative disorder.
  • Hairy cells are now understood to originate from a mature stage of B-cell differentiation.
  • Historically, splenectomy was the primary treatment for HCL.

Purpose of the Study:

  • To review the current understanding of hairy cell leukemia's origin.
  • To summarize the evolution of HCL treatment strategies.
  • To discuss recent advances in HCL therapy.

Main Methods:

  • Immunophenotyping using monoclonal and polyclonal antibodies.
  • Cytochemical analysis.
  • Immunoglobulin gene rearrangement studies.

Related Experiment Videos

Main Results:

  • Established the B-cell origin of neoplastic cells in HCL.
  • Demonstrated splenectomy as a historically valuable therapy.
  • Indicated chemotherapy with alkylating agents as moderately successful.
  • Highlighted alpha-interferon and deoxycoformicin as promising new therapies.

Conclusions:

  • Hairy cell leukemia is a mature B-cell malignancy.
  • Treatment has advanced from splenectomy to include effective chemotherapies and novel agents.
  • Alpha-interferon and deoxycoformicin represent significant progress in HCL management.